Yuval Binur, PhD

DR. Binur has over 30 years of worldwide venture capital and investment experience. Since 2010, Dr. Binur expend his operations to the emerging markets, mostly in China, spending there substantial part of his time. In 2000, Dr. Binur co-founded Accelerated Technologies, Inc. – a highly differentiated investment firm focused on medical technologies and specifically on cardiovascular. Prior to that, Dr. Binur was a founding partner of Medica Venture Partners, Israel’s first dedicated life sciences and medical technologies venture fund. Prior to that and throughout the 80s, Dr. Binur was a member and manager of Adler & Co., a large New York based venture capital firm. Throughout his carrier, Dr. Binur has been a board member of over 40 venture-backed companies in medical devices, pharmaceuticals and other technologies. Among them: PVT (now owned by Edwards Lifesciences), superDimension (now owned by Covidien/Medtronic), Impella (now owned by Abiomed), Memory Pharmaceuticals (now owned by Roche), Pathway Medical (now owned by Bayer), Oxigene Pharmaceuticals (now owned by Roche), Zoran, Accufax and Mitralign, to name a few. Currently Dr. Binur is Charing Sanoculis, Ltd. a late stage glaucoma surgery device and is involved with several other device companies in Israel, US and China.

Throughout his carrier in venture capital, Dr. Binur was involved with major M&A transactions, fund raising and IPOs totaling approx. US$2 Billion.